ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ABIRATERONE ACETATE: products 1 to 18 of 18.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Abiraterone 500mg TabDIN 02525380 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Apo-Abiraterone Film Coated Tablets 250mg TabDIN 02491397 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Apo-Abiraterone Film Coated Tablets 500mg TabDIN 02491400 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Jamp Abiraterone 250mg TabDIN 02502305 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Jamp Abiraterone 500mg TabDIN 02529629 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Mar-Abiraterone 250mg TabDIN 02503980 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Mar-Abiraterone 500mg TabDIN 02503999 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Nat-Abiraterone 250mg TabDIN 02494132 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| PMS-Abiraterone 250mg TabDIN 02492601 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| PMS-Abiraterone 500mg TabDIN 02501503 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Abiraterone 250mg TabDIN 02540452 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Abiraterone 500mg TabDIN 02540460 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Reddy-Abiraterone 250mg TabDIN 02477114 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Reddy-Abiraterone 500mg TabDIN 02533251 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Abiraterone 250mg TabDIN 02486393 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Abiraterone 500mg TabDIN 02521644 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
| Zytiga 250mg TabDIN 02371065 | General benefit | $7.6563per source unit | Requirements & sourcesBuild cost plan |
| Zytiga 500mg TabDIN 02457113 | General benefit | $15.3125per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.